It remains a source of surprise to me just how many excellent stocks exist in the European healthcare sector, and just how much variety there is. This week we are adding one to our long term buy and hold portfolio, buying it at EUR 24.10. We like its excellent value prospects, and believe the stock has been oversold.
This French company designs, develops and manufactures medical devices, especially the sort of personal devices that patients can carry to treat themselves or provide information to doctors. We think this will be a major growth market in the future. This company owns the tech for a whole portfolio of these devices.
The shares have been sold down from about EUR 35 a year ago but have been in rally mode since October last year, when they could have been bought for as list as EUR 14 on Euronext, which we think was a complete steal for a company of this quality. What we do like to see is a bit of price momentum, which shows that the French investment market is buying back into the story.
Want the full story? Access all of The Armchair Trader's content for just £5.99 per month.
Get weekly investment ideas and tips that will take your investing to the next level. Sign up here.
Free 28 day trial. Cancel anytime.
Log In or Sign Up to Armchair Trader+
Already a member? Log in here:
Not a member yet? Sign up for your free trial or check out the benefits of membership.
Further content of this article is not available as it is for members only. Please visit the registration page for Armchair Trader Plus+ for further details on the benefits of becoming a member.